|
Report Date : |
09.07.2012 |
IDENTIFICATION DETAILS
|
Name : |
HEBEI HELI PHARMACEUTICAL CO., LTD. |
|
|
|
|
Registered Office : |
No. 718
Eastern Culture Commodity Market, No.
33 Zhengdong Road, Qiaodong District, Shijiazhuang, Hebei Province 050011 Pr |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
18.01.2010 |
|
|
|
|
Com. Reg. No.: |
130100000282025 |
|
|
|
|
Legal Form : |
Limited Liabilities Company |
|
|
|
|
Line of Business : |
Subject
is engaged in researching, developing, and selling API, pharmaceutical
intermediates and preparation |
|
|
|
|
No. of Employees : |
35 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
HEBEI HELI
PHARMACEUTICAL CO., LTD.
no. 718 Eastern Culture COMMODITY Market
NO. 33 ZHENGDONG ROAD, QIAODONG DISTRICT
shijiazhuang, hebei province 050011 PR CHINA
TEL: 86 (0) 311-86083178/85263188
FAX: 86 (0) 311-86083178
Date of Registration : JANUARY 18, 2010
REGISTRATION NO. : 130100000282025
LEGAL FORM : Limited liabilities company
REGISTERED CAPITAL : cny 3,000,000
staff : 35
BUSINESS CATEGORY : R & D & TRADING
Revenue : CNY 17,955,000 (AS OF DEC. 31, 2011)
EQUITIES : CNY 2,941,000 (AS OF DEC. 31, 2011)
WEBSITE : http://helipharma.com
E-MAIL :
helipharma1@gmail.com
PAYMENT : AVERAGE
MARKET CONDITION : AVERAGE
FINANCIAL CONDITION : FAIRly stable
OPERATIONAL TREND : ORDINARY
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE : CNY 6.36= USD 1
Adopted
abbreviations (as follows)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
SC was
established as a limited liabilities company of PRC with State Administration
of Industry & Commerce (SAIC) under registration No.: 130100000282025 on January 18, 2010.
SC’s Organization Code Certificate
No.: 69924629-X

SC’s registered capital: cny 3,000,000
SC’s paid-in capital: cny 3,000,000
Registration Change Record:-
No significant changes of SC have
been noted in SAIC since its incorporation.
Current Co search indicates SC’s shareholders & chief
executives are as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Li Yiping |
60 |
|
Lu Yuan |
40 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative, Chairman,
and General Manager |
Li Yiping |
|
Supervisor |
Lu Yuan |
No recent development was found during our checks at present.
Name %
of Shareholding
Li Yiping 60
Lu Yuan 40
Li
Yiping, Legal
Representative, Chairman and General Manager
------------------------------------------------------------------------------------------------
Ø
Gender: M
Ø
Age: 47
Ø
ID# 420922196510292019
Ø
Qualification:
University
Ø
Working
experience (s):
From 2010 to present, working in SC as legal representative,
chairman and general manager
Lu
Yuan, Supervisor
------------------------------------
Ø
Gender: F
Ø
Age: 33
Ø
ID# 132401197901120343
SC’s registered business scope includes wholesaling
veterinary medicine raw materials and the preparation of veterinary drugs;
technology research and development for animal drugs; importing and exporting
commodities and technology; and selling chemical materials and products.
SC is
mainly engaged in researching, developing, and selling API, pharmaceutical
intermediates and preparation.
SC’s
products mainly include:
API
Liquid Injection
Solution for oral
Pour-on solution
Tablet
Premix
Powder
Technical material

SC sources its materials 100% from domestic
market. SC sells 60% of its products in domestic market, and 40% to overseas
market, mainly Asia, Africa, Europe, etc.
The
buying terms of SC include Check, T/T and Credit of 30-60 days. The payment
terms of SC include T/T, L/C and Credit of 30-60 days.
Major
Client:
---------------
Hebei
Veyong Bio-Chemical Co., Ltd.
Staff & Office:
--------------------------
SC is
known to have approx. 35
staff at present.
SC
rents an area as its operating office and factory, but the detailed information
is unknown.
SC
is not known to have any subsidiary at present.
Overall payment appraisal:
( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC did not
provide any name of trade/service suppliers and we have no other sources to
conduct the enquiry at present.
Delinquent payment record: None in our
database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
The bank
information of SC is not filed in local SAIC.
Balance Sheet
|
Unit: CNY’000 |
As
of Dec. 31, 2010 |
As
of Dec. 31, 2011 |
|
509 |
389 |
|
|
Notes receivable |
0 |
0 |
|
Accounts
receivable |
0 |
922 |
|
Advances to
suppliers |
4,509 |
2,999 |
|
Other receivable |
0 |
1 |
|
Inventory |
0 |
0 |
|
Non-current
assets within one year |
0 |
0 |
|
Other current
assets |
2 |
30 |
|
|
------------------ |
------------------ |
|
Current assets |
5,020 |
4,341 |
|
Fixed assets |
39 |
38 |
|
Construction in
progress |
0 |
0 |
|
Intangible
assets |
0 |
0 |
|
Long-term
investment |
0 |
0 |
|
Deferred income
tax assets |
0 |
0 |
|
Other
non-current assets |
0 |
0 |
|
|
------------------ |
------------------ |
|
Total assets |
5,059 |
4,379 |
|
|
============= |
============= |
|
Short-term loans |
0 |
0 |
|
Notes payable |
0 |
0 |
|
Accounts payable |
0 |
272 |
|
Wages payable |
55 |
104 |
|
Taxes payable |
8 |
21 |
|
Advances from
clients |
1,560 |
640 |
|
Other payable |
436 |
401 |
|
Other current
liabilities |
0 |
0 |
|
|
------------------ |
------------------ |
|
Current
liabilities |
2,059 |
1,438 |
|
Non-current
liabilities |
0 |
0 |
|
|
------------------ |
------------------ |
|
Total
liabilities |
2,059 |
1,438 |
|
Equities |
3,000 |
2,941 |
|
|
------------------ |
------------------ |
|
Total
liabilities & equities |
5,059 |
4,379 |
|
|
============= |
============= |
Income Statement
|
Unit: CNY’000 |
As of Dec. 31,
2010 |
As of Dec. 31,
2011 |
|
Revenue |
7,219 |
17,955 |
|
Cost of sales |
6,821 |
17,299 |
|
Taxes and surcharges |
8 |
12 |
|
Sales expense |
7 |
62 |
|
Management expense |
383 |
574 |
|
Finance expense |
-1 |
-2 |
|
Non-business
income |
0 |
0 |
|
Non-business expenditure |
0 |
1 |
|
Profit before
tax |
0.2 |
9 |
|
Less: profit tax |
0 |
2 |
|
0.2 |
7 |
Important Ratios
|
|
As
of Dec. 31, 2010 |
As
of Dec. 31, 2011 |
|
*Current ratio |
2.44 |
3.02 |
|
*Quick ratio |
2.44 |
3.02 |
|
*Liabilities
to assets |
0.41 |
0.33 |
|
*Net profit
margin (%) |
0.003 |
0.04 |
|
*Return on
total assets (%) |
0.004 |
0.16 |
|
*Inventory /
Revenue ×365 |
-- |
-- |
|
*Accounts
receivable/ Revenue ×365 |
-- |
19 days |
|
*
Revenue/Total assets |
1.43 |
4.10 |
|
* Cost of
sales / Revenue |
0.94 |
0.96 |
PROFITABILITY:
AVERAGE
l
The revenue of SC appears average, and it was
rising in 2011.
l
SC’s net profit margin is average in both years.
l
SC’s return on total assets is average in both
years.
l
SC’s cost of sales is fairly high, comparing with
its revenue.
LIQUIDITY:
AVERAGE
l
The current ratio of SC is maintained in a fairly
good level in both years.
l
SC’s quick ratio is maintained in a fairly good
level in both years.
l
SC has no inventory.
l
The accounts receivable of SC appears average.
l
SC has no short-term loans.
l
SC’s revenue is in an
average level, comparing with the size of its total assets.
LEVERAGE:
AVERAGE
l
The debt ratio of SC is average.
l
The risk for SC to go bankrupt is above average.
Overall financial
condition of the SC: Fairly Stable.
SC is considered small-sized in its line with
fairly stable financial conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.42 |
|
UK Pound |
1 |
Rs.86.04 |
|
Euro |
1 |
Rs.68.61 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.